ACRO Biomedical Co., Ltd.

ACRO Biomedical was established in June 2014 in Kaohsiung, Taiwan, by Dr. Dar-Jen Hsieh and a group of scientists and physicians. The company is in the leading position of the field of collagen derived medical devices that expertizes in tissue engineering and regenerative medicine of human tissues and organs. The high-end medical devices were produced using the proprietary technology which combines advances in molecular cell biology and supercritical carbon dioxide extraction technology to remove lipids, cells, and non-collagenous proteins from tissues and organs to create natural collagen scaffolds suitable as xenograft biomaterials for tissue engineering and regenerative medicine applications.